Pellegrini-Giampietro Domenico E
Dipartimento di Farmacologia Preclinica e Clinica, Università di Firenze, Viale G. Pieraccini 6, 50139 Florence, Italy.
Trends Pharmacol Sci. 2003 Sep;24(9):461-70. doi: 10.1016/S0165-6147(03)00231-1.
Metabotropic glutamate receptors of the mGlu(1) and mGlu(5) subtypes exhibit a high degree of sequence homology and are both coupled to phospholipase C and intracellular Ca(2+) mobilization. However, functional differences have been detected for these receptor subtypes when they are coexpressed in the same neuronal populations. Experimental evidence indicates that mGlu(1) and mGlu(5) receptors play a differential role in models of cerebral ischemia and that only mGlu(1) receptors are implicated in the pathways leading to post-ischemic neuronal injury. The localization of mGlu(1) receptors in GABA-containing interneurons rather than in hippocampal CA1 pyramidal cells that are vulnerable to ischemia has prompted studies that have provided a new viewpoint on the neuroprotective mechanism of mGlu(1) receptor antagonists. The hypothesis predicts that these pharmacological agents attenuate post-ischemic injury by enhancing GABA-mediated neurotransmission.
代谢型谷氨酸受体的mGlu(1)和mGlu(5)亚型表现出高度的序列同源性,且均与磷脂酶C和细胞内Ca(2+)动员偶联。然而,当这些受体亚型在相同的神经元群体中共表达时,已检测到它们的功能差异。实验证据表明,mGlu(1)和mGlu(5)受体在脑缺血模型中发挥不同作用,且只有mGlu(1)受体参与导致缺血后神经元损伤的途径。mGlu(1)受体定位于含γ-氨基丁酸(GABA)的中间神经元而非易受缺血影响的海马CA1锥体细胞,这促使了相关研究,为mGlu(1)受体拮抗剂的神经保护机制提供了新观点。该假说预测,这些药物通过增强GABA介导的神经传递来减轻缺血后损伤。